TITN · Titan Machinery Inc.

The thesis

Titan Machinery's case is that the farm-equipment cycle has bottomed, and the business has not yet confirmed it. The fiscal third-quarter report, expected around 24 November 2026, decides it: total inventory has to fall below the $931.5 million reported at 31 July 2026, and the fiscal 2027 adjusted earnings range of $17 million to $29 million has to hold.

The shares closed at $22.89 on 21 October 2026, 12.7% below the 52-week high of $26.22 set on 4 September 2026. They are up 14.6% over three months, against 28.9% at the 8 October 2026 close. The 14-day relative strength index (RSI), a momentum gauge running from 0 to 100, is 47.1.

The narrative is maturing: the last new evidence was Baird's 31 August 2026 upgrade, and Titan has issued no results since 27 August 2026. A search of company news found no announcement dated after 9 October 2026 and no date notice yet for the third-quarter report. The evidence stays short of confirming the recovery, so the rating stays at low conviction.

Bullish and bearish views on Titan Machinery Inc.

The bull case on Titan Machinery Inc. (TITN), in brief: Inventory financing costs have fallen sharply. The bear case: Total inventory is still rising.

Bull case

• Inventory financing costs have fallen sharply. Titan's 27 August 2026 release reported second-quarter floorplan interest expense of $3.7 million, down from $6.8 million a year earlier. Floorplan interest is the cost of financing equipment sitting on dealer lots.
• Used equipment is clearing. Used-equipment inventory fell $40 million between 31 January 2026 and 31 July 2026, per the same release. Baird upgraded the shares to Outperform from Neutral on 31 August 2026 and raised its target to $29 from $20, citing equipment inventory down roughly $600 million from the fiscal 2025 second-quarter peak.
• Two segments raised their outlook. On 27 August 2026 Titan raised its fiscal 2027 Construction revenue guide to growth of 5% to 10% and its Australia guide to growth of 15% to 20%.
• Revenue beat expectations. Second-quarter revenue was $496.4 million against a $483.8 million consensus, per the 27 August 2026 release and Benzinga, although it fell 9.2% from $546.4 million a year earlier.

Bear case

• Total inventory is still rising. Titan reported $931.5 million of inventory at 31 July 2026, up $28.4 million from 31 January 2026. New-equipment stock is offsetting the used-equipment reduction.
• Losses are widening. The second-quarter diluted loss was $(0.40) per share against $(0.26) a year earlier and a $(0.36) consensus. Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) fell to $4.6 million from $5.6 million.
• Full-year guidance still points to a loss. On 27 August 2026 Titan reaffirmed fiscal 2027 adjusted EBITDA of $17 million to $29 million and an adjusted diluted loss of $(1.25) to $(1.75) per share. It did not raise either range.
• Europe is deteriorating. The same release cut the Europe revenue guide to a decline of 30% to 40%.
• Thin cash against heavy floorplan debt. Cash was $29.5 million and floorplan payable was $623.6 million at 31 July 2026.
• Analyst targets cluster near the price. B. Riley rated the shares Hold with a $22 target on 28 August 2026. Stockanalysis.com listed a four-analyst average target of $25.25 on 2 September 2026.

Price setup

The adjusted close on 21 October 2026 was $22.89. That is below the $23 weekly-close level named in the previous note, and below the $23.12 midday price MarketBeat reported on 7 October 2026 after an 8.3% drop with no company news.

MarketBeat put the 50-day moving average at $21.39 and the 200-day moving average at $20.24 on 7 October 2026. Both sat below the price then, and the shares remain above the 200-day level.

Crowding evidence is limited. The third-quarter report is about five weeks away, and no insider transactions or share issuance have been reported.

Catalysts, next 30 days

• ~10 November 2026, est.: Titan's date notice for the third-quarter report. Titan issued the notice on 11 November 2025 last year, two weeks ahead of its 25 November 2025 report.
• ~24 November 2026, est.: Fiscal 2027 third-quarter results. Falls just outside the 30-day window. It shows whether inventory is below $931.5 million and whether the earnings range survives.

Elapsed catalysts

• ~30 October 2026, est.: CNH Industrial third-quarter results. CNH makes the Case IH and New Holland equipment Titan sells; its commentary on dealer inventory and pricing bears on Titan's stock levels. The date is an estimate from CNH's prior-year schedule. (passed 7d ago)
• 31 October 2026: Titan's fiscal third quarter ends. The inventory figure at this date is the one the case turns on. (passed 6d ago)

What would change the view

The case breaks if the fiscal third-quarter balance sheet shows total inventory above $931.5 million, or if Titan cuts the $17 million to $29 million fiscal 2027 adjusted EBITDA range. A Europe revenue guide worse than the 30% to 40% decline set on 27 August 2026 would also weaken it.

On price, a daily close below $20, under the 200-day moving average of $20.24 that MarketBeat reported on 7 October 2026, would show the recovery move has been fully reversed. The rating would rise if the report shows inventory falling alongside an intact or raised earnings range.

What it trades with

Titan sells mainly CNH Industrial equipment, so CNH's results and pricing feed directly into Titan's inventory and margins. Deere and AGCO results track the same farm-equipment cycle.

Crop prices and farm income, which the USDA's monthly supply reports update, drive demand for its agricultural segment. Floorplan financing makes Titan sensitive to short-term interest rates. The shares sit in the small-cap Russell 2000 index and trade thinly, so small-cap flows can move them without company news.